Mumbai, September 9 (Kiran News) — Amanta Healthcare made a strong debut on the Bombay Stock Exchange (BSE) on Tuesday, listing at ₹134.00, a 6.35 percent premium over its issue price of ₹126.00 per share.
Post listing, the stock was trading at ₹133.50, up by ₹7.50 or 5.95 percent from the issue price. It touched an intraday high of ₹140.00 and a low of ₹132.00, with around 2.92 lakh shares changing hands.
The company’s initial public offering (IPO), which remained open between September 1 and September 3, 2025, was subscribed 82.60 times, reflecting strong investor demand. The issue price was fixed at ₹126 per share, the upper end of the price band of ₹120–₹126 apiece.
Amanta Healthcare is engaged in the development, manufacturing, and marketing of a wide range of sterile liquid products, particularly parenteral products, packed in plastic containers using ABFS and ISBM technology.
Bhupendra Singh Chundawat is a seasoned technology journalist with over 22 years of experience in the media industry. He specializes in covering the global technology landscape, with a deep focus on manufacturing trends and the geopolitical impact on tech companies. Currently serving as the Editor at Udaipur Kiran, his insights are shaped by decades of hands-on reporting and editorial leadership in the fast-evolving world of technology.